NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
Back to search
Official data from USPTO
FIDVAXI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
02/08/2025
Trademark type
Combined
Nice classes
42
Filing date
09/01/2022
Registration date
11/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
02/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
VAUSS, JERAMEY
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genexine, Inc.
Representatives
Leigh Ann Lindquist Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/27/2024
FIMP
FINAL DISPOSITION PROCESSED
02/27/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/13/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/13/2023
RFNT
REFUSAL PROCESSED BY IB
02/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2023
RFRR
REFUSAL PROCESSED BY MPU
01/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2022
CNRT
NON-FINAL ACTION WRITTEN
11/02/2022
DOCK
ASSIGNED TO EXAMINER
11/02/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/20/2022
Continuous trademark protection
Get notified about every new filing that threatens FIDVAXI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.